Global Gene Interference Service 麻豆原创 Research Report 2024

Publication ID:

PB508249547

Publication Date:

August 5, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Gene interference service is a kind of service that provides methods to selectively suppress the expression of specific genes, such as RNA interference (RNAi) or CRISPR interference (CRISPRi), to study gene functions or develop potential gene-based therapies.
The global Gene Interference Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gene Interference Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gene Interference Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gene Interference Service in Pharmaceutical Industry is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gene Interference Service include Creative Biogene, Altogen Labs, Azenta Life Sciences, Cellecta, Synbio-Tech, Sirnaomics, Atalanta Therapeutics, Arcturus Therapeutics Holdings and Beijing Tsingke Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Interference Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Interference Service.
Report Scope
The Gene Interference Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Interference Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Interference Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Creative Biogene
Altogen Labs
Azenta Life Sciences
Cellecta
Synbio-Tech
Sirnaomics
Atalanta Therapeutics
Arcturus Therapeutics Holdings
Beijing Tsingke Biotech
Obiosh
Abace-Biology
ACE Biolabs
Brainvta
Segment by Type
siRNA/miRNA Synthesis
shRNA Lentiviral Plasmid construction
Others
Segment by Application
Pharmaceutical Industry
Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Interference Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Gene Interference Service 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 siRNA/miRNA Synthesis
1.2.3 shRNA Lentiviral Plasmid construction
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Gene Interference Service 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industry
1.3.3 Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Interference Service 麻豆原创 Perspective (2019-2030)
2.2 Gene Interference Service Growth Trends by Region
2.2.1 Global Gene Interference Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Interference Service Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Gene Interference Service Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Gene Interference Service 麻豆原创 Dynamics
2.3.1 Gene Interference Service Industry Trends
2.3.2 Gene Interference Service 麻豆原创 Drivers
2.3.3 Gene Interference Service 麻豆原创 Challenges
2.3.4 Gene Interference Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Interference Service Players by Revenue
3.1.1 Global Top Gene Interference Service Players by Revenue (2019-2024)
3.1.2 Global Gene Interference Service Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Gene Interference Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Interference Service Revenue
3.4 Global Gene Interference Service 麻豆原创 Concentration Ratio
3.4.1 Global Gene Interference Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Interference Service Revenue in 2023
3.5 Gene Interference Service Key Players Head office and Area Served
3.6 Key Players Gene Interference Service Product Solution and Service
3.7 Date of Enter into Gene Interference Service 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Interference Service Breakdown Data by Type
4.1 Global Gene Interference Service Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Gene Interference Service Forecasted 麻豆原创 Size by Type (2025-2030)
5 Gene Interference Service Breakdown Data by Application
5.1 Global Gene Interference Service Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Gene Interference Service Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Gene Interference Service 麻豆原创 Size (2019-2030)
6.2 North America Gene Interference Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Interference Service 麻豆原创 Size by Country (2019-2024)
6.4 North America Gene Interference Service 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Interference Service 麻豆原创 Size (2019-2030)
7.2 Europe Gene Interference Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Interference Service 麻豆原创 Size by Country (2019-2024)
7.4 Europe Gene Interference Service 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Interference Service 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Gene Interference Service 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Interference Service 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Gene Interference Service 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Interference Service 麻豆原创 Size (2019-2030)
9.2 Latin America Gene Interference Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Interference Service 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Gene Interference Service 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Interference Service 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Gene Interference Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Interference Service 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Gene Interference Service 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biogene
11.1.1 Creative Biogene Company Detail
11.1.2 Creative Biogene Business Overview
11.1.3 Creative Biogene Gene Interference Service Introduction
11.1.4 Creative Biogene Revenue in Gene Interference Service Business (2019-2024)
11.1.5 Creative Biogene Recent Development
11.2 Altogen Labs
11.2.1 Altogen Labs Company Detail
11.2.2 Altogen Labs Business Overview
11.2.3 Altogen Labs Gene Interference Service Introduction
11.2.4 Altogen Labs Revenue in Gene Interference Service Business (2019-2024)
11.2.5 Altogen Labs Recent Development
11.3 Azenta Life Sciences
11.3.1 Azenta Life Sciences Company Detail
11.3.2 Azenta Life Sciences Business Overview
11.3.3 Azenta Life Sciences Gene Interference Service Introduction
11.3.4 Azenta Life Sciences Revenue in Gene Interference Service Business (2019-2024)
11.3.5 Azenta Life Sciences Recent Development
11.4 Cellecta
11.4.1 Cellecta Company Detail
11.4.2 Cellecta Business Overview
11.4.3 Cellecta Gene Interference Service Introduction
11.4.4 Cellecta Revenue in Gene Interference Service Business (2019-2024)
11.4.5 Cellecta Recent Development
11.5 Synbio-Tech
11.5.1 Synbio-Tech Company Detail
11.5.2 Synbio-Tech Business Overview
11.5.3 Synbio-Tech Gene Interference Service Introduction
11.5.4 Synbio-Tech Revenue in Gene Interference Service Business (2019-2024)
11.5.5 Synbio-Tech Recent Development
11.6 Sirnaomics
11.6.1 Sirnaomics Company Detail
11.6.2 Sirnaomics Business Overview
11.6.3 Sirnaomics Gene Interference Service Introduction
11.6.4 Sirnaomics Revenue in Gene Interference Service Business (2019-2024)
11.6.5 Sirnaomics Recent Development
11.7 Atalanta Therapeutics
11.7.1 Atalanta Therapeutics Company Detail
11.7.2 Atalanta Therapeutics Business Overview
11.7.3 Atalanta Therapeutics Gene Interference Service Introduction
11.7.4 Atalanta Therapeutics Revenue in Gene Interference Service Business (2019-2024)
11.7.5 Atalanta Therapeutics Recent Development
11.8 Arcturus Therapeutics Holdings
11.8.1 Arcturus Therapeutics Holdings Company Detail
11.8.2 Arcturus Therapeutics Holdings Business Overview
11.8.3 Arcturus Therapeutics Holdings Gene Interference Service Introduction
11.8.4 Arcturus Therapeutics Holdings Revenue in Gene Interference Service Business (2019-2024)
11.8.5 Arcturus Therapeutics Holdings Recent Development
11.9 Beijing Tsingke Biotech
11.9.1 Beijing Tsingke Biotech Company Detail
11.9.2 Beijing Tsingke Biotech Business Overview
11.9.3 Beijing Tsingke Biotech Gene Interference Service Introduction
11.9.4 Beijing Tsingke Biotech Revenue in Gene Interference Service Business (2019-2024)
11.9.5 Beijing Tsingke Biotech Recent Development
11.10 Obiosh
11.10.1 Obiosh Company Detail
11.10.2 Obiosh Business Overview
11.10.3 Obiosh Gene Interference Service Introduction
11.10.4 Obiosh Revenue in Gene Interference Service Business (2019-2024)
11.10.5 Obiosh Recent Development
11.11 Abace-Biology
11.11.1 Abace-Biology Company Detail
11.11.2 Abace-Biology Business Overview
11.11.3 Abace-Biology Gene Interference Service Introduction
11.11.4 Abace-Biology Revenue in Gene Interference Service Business (2019-2024)
11.11.5 Abace-Biology Recent Development
11.12 ACE Biolabs
11.12.1 ACE Biolabs Company Detail
11.12.2 ACE Biolabs Business Overview
11.12.3 ACE Biolabs Gene Interference Service Introduction
11.12.4 ACE Biolabs Revenue in Gene Interference Service Business (2019-2024)
11.12.5 ACE Biolabs Recent Development
11.13 Brainvta
11.13.1 Brainvta Company Detail
11.13.2 Brainvta Business Overview
11.13.3 Brainvta Gene Interference Service Introduction
11.13.4 Brainvta Revenue in Gene Interference Service Business (2019-2024)
11.13.5 Brainvta Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Creative Biogene
Altogen Labs
Azenta Life Sciences
Cellecta
Synbio-Tech
Sirnaomics
Atalanta Therapeutics
Arcturus Therapeutics Holdings
Beijing Tsingke Biotech
Obiosh
Abace-Biology
ACE Biolabs
Brainvta

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.